|
Hematein
|
氧化苏木精
|
475-25-2
|
|
WYE-354
|
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯
|
1062169-56-5
|
|
GSK1059615
|
(5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮
|
958852-01-2
|
|
Rigosertib sodium
|
瑞格色替钠
|
592542-60-4
|
|
Rigosertib
|
瑞格色替
|
592542-59-1
|
|
KU-60019
|
KU 60019
|
925701-46-8
|
|
PHT-427
|
4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺
|
1191951-57-1
|
|
JR-AB2-011
|
JR-AB2-011
|
2411853-34-2
|
|
STL127705
|
化合物STL127705
|
1326852-06-5
|
|
Umbralisib hydrochloride
|
1532533-78-0
|
1532533-78-0
|
|
Serabelisib
|
[6-(2-氨基-5-苯并恶唑基)咪唑并[1,2-A]吡啶-3-基]-4-吗啉基甲酮
|
1268454-23-4
|
|
Borussertib
|
Borussertib
|
1800070-77-2
|
|
BX517
|
PDK1 INHIBITOR
|
850717-64-5
|
|
(R)-PS210
|
Propanedioic acid, 2-[(1R)-3-oxo-1-phenyl-3-[4-(trifluoroMethyl)phenyl]propyl]-
|
1410101-89-1
|
|
PF-4989216
|
4-(4-氰基-2-氟苯基)-2-吗啉-5-(1H-1,2,4-三唑-5-基)噻吩-3-腈
|
1276553-09-3
|
|
Taselisib
|
GDC 0032
|
1282512-48-4
|
|
GSK-3 inhibitor 1
|
3-(9-氟-1,2,3,4-四氢吡咯并[3,2,1-JK][1,4]苯并二氮杂卓-7-基)-4-咪唑并[1,2-A]吡啶-3-基-1H-吡咯-2,5-二酮单盐酸盐
|
603272-51-1
|
|
MP7
|
PDK1 抑制剂
|
1001409-50-2
|
|
Palomid 529
|
PALOMID 529 (P529)
|
914913-88-5
|
|
GSK2334470
|
GSK2334470
|
1227911-45-6
|
|
Dactolisib Tosylate
|
BEZ235 对甲苯磺酸盐
|
1028385-32-1
|
|
PF-04691502
|
2-氨基-8-[反式-4-(2-羟基乙氧基)环己基]-6-(6-甲氧基-3-吡啶基)-4-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮
|
1013101-36-4
|
|
Buparlisib Hydrochloride
|
BKM120(盐酸盐)
|
1312445-63-8
|
|
Ipatasertib dihydrochloride
|
(2S)-2-(4-氯苯基)-1-[4-[(5R,7R)-6,7-二氢-7-羟基-5-甲基-5H-环戊并嘧啶-4-基]-1-哌嗪基]-3-[(1-甲基乙基)氨基]-1-丙酮二盐酸盐
|
1396257-94-5
|
|
Alpelisib
|
阿培利司
|
1217486-61-7
|
|
GSK2636771
|
GSK2636771
|
1372540-25-4
|
|
GDC-0349
|
N-ETHYL-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(3-氧杂环丁基)吡啶并[3,4-D]嘧啶-2-基]苯基]脲
|
1207360-89-1
|
|
WYE-687 dihydrochloride
|
WYE-687二盐酸盐
|
1702364-87-1
|
|
CZC24832
|
5-(2-氨基-8-氟[1,2,4]三唑并[1,5-A]吡啶-6-基)-N-(叔丁基)-3-吡啶磺酰胺
|
1159824-67-5
|
|
Copanlisib dihydrochloride
|
Copanlisib
|
1402152-13-9
|
|
BIO-acetoxime
|
6-溴靛玉红-3'-丙酮肟
|
667463-85-6
|
|
FPA-124
|
AKT 抗化剂
|
902779-59-3
|
|
CH5132799
|
CH5132799
|
1007207-67-1
|
|
OTSSP167 hydrochloride
|
OTSSP 167 盐酸盐
|
1431698-10-0
|
|
CGK733
|
CGK 733
|
905973-89-9
|
|
KP-23172
|
6H-INDENO[1,2-E]TETRAZOLO[1,5-B][1,2,4]TRIAZIN-6-ONE
|
1374996-60-7
|
|
IM-12
|
IM-12
|
1129669-05-1
|
|
AZD8186
|
8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺
|
1627494-13-6
|
|
ON 146040
|
1404231-34-0
|
1404231-34-0
|
|
ETP-46321
|
CS-2500
|
1252594-99-2
|
|
JNJ-47117096 hydrochloride
|
1610536-69-0
|
1610536-69-0
|
|
(R)-BRD3731
|
|
2056262-08-7
|
|
BRD3731
|
5H-Pyrazolo[3,4-b]quinolin-5-one, 3-(2,2-dimethylpropyl)-1,2,4,6,7,8-hexahydro-4,7,7-trimethyl-4-phenyl-, (4S)-
|
2056262-07-6
|
|
Vps34-IN-2
|
(S)-1-(3-methyl-2-oxobutyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one
|
1523404-29-6
|
|
Rheb inhibitor NR1
|
化合物 T16741
|
2216763-38-9
|
|
Samotolisib
|
LY-3023414
|
1386874-06-1
|
|
GSK-3β inhibitor 1
|
2H-Indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-, (3Z)-
|
187325-53-7
|
|
Acalisib
|
GS-9820
|
870281-34-8
|
|
GNE-317
|
GNE-317
|
1394076-92-6
|
|
Vps34-IN-1
|
VPS34-IN1
|
1383716-33-3
|
|
Ampkinone
|
CS-2123
|
1233082-79-5
|
|
Bimiralisib
|
PI3K/MTOR抑制剂
|
1225037-39-7
|
|
AZD-8835
|
AZD-8835
|
1620576-64-8
|
|
AMG319
|
AMG319
|
1608125-21-8
|
|
PI4KIII beta inhibitor 3
|
4-(5-AMINO-2-PYRIDIN-3-YL-THIAZOLO[5,4-D]PYRIMIDIN-7-YL)-PIPERAZINE-1-CARBOXYLIC ACID P-TOLYLAMIDE
|
1245319-54-3
|
|
NU 7026
|
2-(4-吗啉基)-4H-萘并[1,2-B]吡喃-4-酮
|
154447-35-5
|
|
SAR-260301
|
(S)-2-(2-(2-甲基吲哚啉-1-基)-2-氧代乙基)-6-吗啉嘧啶-4(3H)-酮
|
1260612-13-2
|
|
HS-173
|
HS-173
|
1276110-06-5
|
|
Voxtalisib
|
VOXTALISIB
|
934493-76-2
|
|
Uprosertib
|
UPROSERTIB
|
1047634-65-0
|
|
CAL-130 Hydrochloride
|
2-[(1S)-1-[(2-氨基-9H-嘌呤-6-基)氨基]乙基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮盐酸盐
|
1431697-78-7
|
|
LY2090314
|
LY 2090314
|
603288-22-8
|
|
NVP-QAV-572
|
N-[2-[2-(2-氟乙基)-2H-四唑-5-基]乙基]-N'-[5-[3-氟-4-(甲基磺酰基)苯基]-4-甲基-2-噻唑基]脲
|
957209-68-6
|
|
Phenformin hydrochloride
|
盐酸苯乙福明
|
834-28-6
|
|
Pilaralisib
|
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺
|
934526-89-3
|
|
VS-5584
|
VS-5584
|
1246560-33-7
|
|
CNX-1351
|
CNX1351
|
1276105-89-5
|
|
3CAI
|
2-氯-1-(1H-吲哚-3-基)-乙酮
|
28755-03-5
|
|
ZLN024 hydrochloride
|
ZLN-024 hydrochloride
|
1883548-91-1
|
|
Seletalisib
|
UCB5857
|
1362850-20-1
|
|
CC-223
|
CC-223
|
1228013-30-6
|
|
CC-115 hydrochloride
|
1300118-55-1
|
1300118-55-1
|
|
Duvelisib
|
IPI-145
|
1201438-56-3
|
|
Duvelisib (R enantiomer)
|
1261590-48-0
|
1261590-48-0
|
|
GNF4877
|
GNF4877
|
2041073-22-5
|
|
Torin 2
|
9-(6-氨基-3-吡啶基)-1-[3-(三氟甲基)苯基]苯并[H]-1,6-萘啶-2(1H)-酮
|
1223001-51-1
|
|
Idelalisib
|
艾代拉里斯
|
870281-82-6
|
|
VO-Ohpic trihydrate
|
VO-OHPIC 三水合物
|
476310-60-8
|
|
GSK-3β inhibitor 2
|
GSK-3 β inhibitor 2
|
1702428-31-6
|
|
KY19382
|
KY19382
|
2226664-93-1
|
|
CCT128930
|
CCT128930
|
885499-61-6
|
|
A66
|
A66
|
1166227-08-2
|
|
BGT226 maleate
|
NVP-BGT226
|
1245537-68-1
|
|
AICAR phosphate
|
5-氨基-1-核糖基咪唑-4-甲酰胺磷酸盐
|
681006-28-0
|
|
Deguelin
|
魚藤素
|
522-17-8
|
|
AMG 511
|
(R)-4-(2-((5-氟-6-甲氧基吡啶-3-基)氨基)-5-(1-(4-(甲基磺酰基)哌嗪-1-基)乙基)吡啶-3-基)-6-甲基-1,3,5-三嗪-2-胺
|
1253573-53-3
|
|
TG 100713
|
TG 100713,3-(2,4-DIAMINO-6-PTERIDINYL)-PHENOL
|
925705-73-3
|
|
CAY10505
|
CAY10505
|
1218777-13-9
|
|
AS-604850
|
5-[(2,2-二氟-1,3-苯并二恶茂-5-基)亚甲基]噻唑烷-2,4-二酮
|
648449-76-7
|
|
AS-252424
|
5-[[5-(4-氟-2-羟基苯基)-2-呋喃基]亚甲基]-2,4-噻唑烷二酮
|
900515-16-4
|
|
MSC2360844
|
MSC2360844
|
1305267-37-1
|
|
MSC2360844 hemifumarate
|
|
1621688-31-0
|
|
IM156
|
IM156
|
1422365-94-3
|
|
SRX3207
|
7H-Thieno[3,2-b]pyran-7-one, 3-[4-[[4-[4-(1-azetidinylmethyl)-3-methyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]phenyl]-5-(4-morpholinyl)-
|
2254693-15-5
|
|
ATR inhibitor 2
|
2-氨基-6-氟-N-(5-氟-4-(4-(4-(噁丁环烷-3-基)哌嗪-1-羰基)哌啶-1-基)吡啶-3-基)吡唑并[1,5-A]嘧啶-3-甲酰胺
|
1613191-99-3
|
|
ASP4132
|
(6-(1-((6-甲氧基吡啶-3-基)甲基)哌啶-4-基)-1H-苯并[D]咪唑-2-基)(4-(4-(三氟甲基)苄基)哌嗪-1-基)甲酮 双对甲苯磺酸盐
|
1640294-30-9
|
|
PQR626
|
无中文名称
|
1927857-98-4
|
|
TMBIM6 antagonist-1
|
1-（2-氨基苯基）-3-（3-硝基苯基）-2-丙烯-1-酮
|
123134-61-2
|
|
SAR502250
|
SAR502250
|
503860-57-9
|
|
XL388
|
[7-(6-氨基-3-吡啶基)-2,3-二氢-1,4-苯并氧氮杂卓-4(5H)-基][3-氟-2-甲基-4-(甲基磺酰基)苯基]-甲酮
|
1251156-08-7
|